SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-293735
Filing Date
2020-11-16
Accepted
2020-11-16 07:01:02
Documents
14
Period of Report
2020-11-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d53512d8k.htm   iXBRL 8-K 26277
2 EX-99.1 d53512dex991.htm EX-99.1 20725
3 EX-99.2 d53512dex992.htm EX-99.2 15184
  Complete submission text file 0001193125-20-293735.txt   196485

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrna-20201116.xsd EX-101.SCH 3094
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrna-20201116_lab.xml EX-101.LAB 17374
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrna-20201116_pre.xml EX-101.PRE 10969
7 EXTRACTED XBRL INSTANCE DOCUMENT d53512d8k_htm.xml XML 3228
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 201313614
SIC: 2836 Biological Products, (No Diagnostic Substances)